FDA NDC Directory · JSON-LD · Markdown
NDC 55910-830 · HUMAN OTC DRUG · CAPSULE, LIQUID FILLED
| Labeler / Manufacturer | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA202300 |
| Dosage form / route | CAPSULE, LIQUID FILLED · ORAL |
| Active ingredients | IBUPROFEN (200 mg/1) |
| Marketing started | 20220316 |
| Package count | 5 |
Source: openFDA. Public-domain (CC0).